Knoll Capital Management
4
51M
4
3
- Areas of investment
Summary
Among the most popular portfolio startups of the fund, we may highlight Exicure, Biohaven Pharmaceutical, electroCore. The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Neuroscience, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Knoll Capital Management, startups are often financed by Tempus, Patrick G. Ryan, Merck Global Health Innovation Fund. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Venrock, Total Access Fund.
The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2018. Comparing to the other companies, this Knoll Capital Management performs on 38 percentage points more the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2017.
The overall number of key employees were 1.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 3
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Therapeutics (2)
- Pharmaceutical (2)
- Life Science (1) Show 7 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 42
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| electroCore | 29 Nov 2017 | Health Care, Medical Device, Therapeutics | Early Stage Venture | 34M | United States, New Jersey |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.